Clinical Trial Update: Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating perioperative chemotherapy and immunotherapy for locally recurrent nasopharyngeal carcinoma; the study is currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: The University of Hong Kong | Conditions: Nasopharyngeal Cancer Recurrent, Nasopharyngeal Cancinoma (NPC) | Phase 2 | Status: NOT_YET_RECRUITING